<!DOCTYPE html>
<html lang="" xml:lang="">
  <head>
    <title>Minimally Clinically Important Difference</title>
    <meta charset="utf-8" />
    <meta name="author" content="Boncho Ku, Ph.D.Â in Statistics" />
    <script src="libs/header-attrs/header-attrs.js"></script>
    <link href="libs/remark-css/default.css" rel="stylesheet" />
    <link href="libs/remark-css/metropolis.css" rel="stylesheet" />
    <link href="libs/remark-css/metropolis-fonts.css" rel="stylesheet" />
    <script src="libs/kePrint/kePrint.js"></script>
    <link href="libs/lightable/lightable.css" rel="stylesheet" />
    <link rel="stylesheet" href="../assets/css/footer.css" type="text/css" />
    <link rel="stylesheet" href="../assets/css/metropolis-ak.css" type="text/css" />
  </head>
  <body>
    <textarea id="source">
class: middle, left, title-slide

# Minimally Clinically Important Difference
## Review in Statistical Aspects
### <strong>Boncho Ku, Ph.D.Â in Statistics</strong>
### <br/> Korea Institute of Oriental Medicine
### <br> 2021/03/23

---










# ğŸ‘‹ Hello

### me: **Boncho Ku**

- **Statistician**, _Korea Institute of Oriental Medicine_
    + github: **@zorba78**
    + email: **secondmoon@kiom.re.kr**

- **Team**: Clinical Research Coordinating Team    


### Current Works in KIOM

.pull-left[
#### **Data Science**
- Statistical learning model
- Text mining
- Data linkage/statistical matching
- Data management
]


.pull-right[
#### **Biostatistics**
- Experiment &amp; study design: RCT and observational study 
- Sample size calculation
- Statistical consulting
]


and providing several lectures related to R programming and statistics


#### Slides: **https://zorba78.github.io/talk-gallery**

---

# &lt;svg viewBox="0 0 384 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M336 64h-80c0-35.3-28.7-64-64-64s-64 28.7-64 64H48C21.5 64 0 85.5 0 112v352c0 26.5 21.5 48 48 48h288c26.5 0 48-21.5 48-48V112c0-26.5-21.5-48-48-48zM96 424c-13.3 0-24-10.7-24-24s10.7-24 24-24 24 10.7 24 24-10.7 24-24 24zm0-96c-13.3 0-24-10.7-24-24s10.7-24 24-24 24 10.7 24 24-10.7 24-24 24zm0-96c-13.3 0-24-10.7-24-24s10.7-24 24-24 24 10.7 24 24-10.7 24-24 24zm96-192c13.3 0 24 10.7 24 24s-10.7 24-24 24-24-10.7-24-24 10.7-24 24-24zm128 368c0 4.4-3.6 8-8 8H168c-4.4 0-8-3.6-8-8v-16c0-4.4 3.6-8 8-8h144c4.4 0 8 3.6 8 8v16zm0-96c0 4.4-3.6 8-8 8H168c-4.4 0-8-3.6-8-8v-16c0-4.4 3.6-8 8-8h144c4.4 0 8 3.6 8 8v16zm0-96c0 4.4-3.6 8-8 8H168c-4.4 0-8-3.6-8-8v-16c0-4.4 3.6-8 8-8h144c4.4 0 8 3.6 8 8v16z"&gt;&lt;/path&gt;&lt;/svg&gt; Outline


## &lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M61.77 401l17.5-20.15a19.92 19.92 0 0 0 5.07-14.19v-3.31C84.34 356 80.5 352 73 352H16a8 8 0 0 0-8 8v16a8 8 0 0 0 8 8h22.83a157.41 157.41 0 0 0-11 12.31l-5.61 7c-4 5.07-5.25 10.13-2.8 14.88l1.05 1.93c3 5.76 6.29 7.88 12.25 7.88h4.73c10.33 0 15.94 2.44 15.94 9.09 0 4.72-4.2 8.22-14.36 8.22a41.54 41.54 0 0 1-15.47-3.12c-6.49-3.88-11.74-3.5-15.6 3.12l-5.59 9.31c-3.72 6.13-3.19 11.72 2.63 15.94 7.71 4.69 20.38 9.44 37 9.44 34.16 0 48.5-22.75 48.5-44.12-.03-14.38-9.12-29.76-28.73-34.88zM496 224H176a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h320a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-160H176a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h320a16 16 0 0 0 16-16V80a16 16 0 0 0-16-16zm0 320H176a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h320a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zM16 160h64a8 8 0 0 0 8-8v-16a8 8 0 0 0-8-8H64V40a8 8 0 0 0-8-8H32a8 8 0 0 0-7.14 4.42l-8 16A8 8 0 0 0 24 64h8v64H16a8 8 0 0 0-8 8v16a8 8 0 0 0 8 8zm-3.91 160H80a8 8 0 0 0 8-8v-16a8 8 0 0 0-8-8H41.32c3.29-10.29 48.34-18.68 48.34-56.44 0-29.06-25-39.56-44.47-39.56-21.36 0-33.8 10-40.46 18.75-4.37 5.59-3 10.84 2.8 15.37l8.58 6.88c5.61 4.56 11 2.47 16.12-2.44a13.44 13.44 0 0 1 9.46-3.84c3.33 0 9.28 1.56 9.28 8.75C51 248.19 0 257.31 0 304.59v4C0 316 5.08 320 12.09 320z"&gt;&lt;/path&gt;&lt;/svg&gt;  **Table of Contents**

&lt;br&gt;

&gt; ### 1. Small talks about Statistics
&gt;
&gt; ### 2. Minimally Clinically Important Change (MCID)
&gt;
&gt; ### 3. Discussion










---

class: inverse, center, middle

# &lt;img src="assets/icons/gaussian-function.svg" width="7%"/&gt;&lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M505 442.7L405.3 343c-4.5-4.5-10.6-7-17-7H372c27.6-35.3 44-79.7 44-128C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c48.3 0 92.7-16.4 128-44v16.3c0 6.4 2.5 12.5 7 17l99.7 99.7c9.4 9.4 24.6 9.4 33.9 0l28.3-28.3c9.4-9.4 9.4-24.6.1-34zM208 336c-70.7 0-128-57.2-128-128 0-70.7 57.2-128 128-128 70.7 0 128 57.2 128 128 0 70.7-57.2 128-128 128z"&gt;&lt;/path&gt;&lt;/svg&gt; Small talks about Statistics 



---

# &lt;img src="assets/icons/history.svg" width="6%"/&gt; History of "_statistical significance_"

### &lt;svg viewBox="0 0 256 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M168 345.941V44c0-6.627-5.373-12-12-12h-56c-6.627 0-12 5.373-12 12v301.941H41.941c-21.382 0-32.09 25.851-16.971 40.971l86.059 86.059c9.373 9.373 24.569 9.373 33.941 0l86.059-86.059c15.119-15.119 4.411-40.971-16.971-40.971H168z"&gt;&lt;/path&gt;&lt;/svg&gt; Flows

&gt; - Edgeworth firstly mentioned (Edgeworth, 1885)
&gt;
&gt; - Sir Ronard A. Fisher described "_the test of significance_" in his book &lt;**_Statistical Methods for Research Workers_**&gt;
&gt;
&gt; - Original intention
&gt;     - **FY. Edgeworth**: mentioned as a tool to indicate when a result needs further scrutiny
&gt;     - **RA. Fisher**: intended to blend data and background knowledge to lead to scientific conclusions


In the 19&lt;sup&gt;th&lt;/sup&gt; century `\(\rightarrow\)` **the obtained value shows something meaningful**


In the 20&lt;sup&gt;th&lt;/sup&gt; century `\(\rightarrow\)` "**_very important_**"


---

# &lt;img src="assets/icons/history.svg" width="6%"/&gt; History of "_statistical significance_"


### &lt;svg viewBox="0 0 256 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M168 345.941V44c0-6.627-5.373-12-12-12h-56c-6.627 0-12 5.373-12 12v301.941H41.941c-21.382 0-32.09 25.851-16.971 40.971l86.059 86.059c9.373 9.373 24.569 9.373 33.941 0l86.059-86.059c15.119-15.119 4.411-40.971-16.971-40.971H168z"&gt;&lt;/path&gt;&lt;/svg&gt; Flows (_continued_)

&gt; - Evidence-based decision making movement
&gt;
&gt; - Lead by the most influential statisticians (**Jerzy Neyman** and **Egon Pearson**)
&gt;
&gt; - Neyman &amp; Pearson introduced: 
&gt;   - Statistical power, false positive, false negative and so many important concepts related to statistics
&gt;   - Intendedly left out the **_P-value_**

---


# &lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M478.21 334.093L336 256l142.21-78.093c11.795-6.477 15.961-21.384 9.232-33.037l-19.48-33.741c-6.728-11.653-21.72-15.499-33.227-8.523L296 186.718l3.475-162.204C299.763 11.061 288.937 0 275.48 0h-38.96c-13.456 0-24.283 11.061-23.994 24.514L216 186.718 77.265 102.607c-11.506-6.976-26.499-3.13-33.227 8.523l-19.48 33.741c-6.728 11.653-2.562 26.56 9.233 33.037L176 256 33.79 334.093c-11.795 6.477-15.961 21.384-9.232 33.037l19.48 33.741c6.728 11.653 21.721 15.499 33.227 8.523L216 325.282l-3.475 162.204C212.237 500.939 223.064 512 236.52 512h38.961c13.456 0 24.283-11.061 23.995-24.514L296 325.282l138.735 84.111c11.506 6.976 26.499 3.13 33.227-8.523l19.48-33.741c6.728-11.653 2.563-26.559-9.232-33.036z"&gt;&lt;/path&gt;&lt;/svg&gt; Argue in the Statistical Significance 

## The Origin &lt;img src="assets/icons/original.svg" width="4%"/&gt;

&gt; **A fierce debate between the most famous statisticians in the history of statistics**

--

.pull-left[
&lt;img src="assets/imgs/RA-Fisher.jpg" width="46%"/&gt; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;img src="assets/icons/fists.svg" width="40%"/&gt;
] 
.pull-right[
&lt;img src="assets/imgs/E-Pearson-02.jpeg" width="43%"/&gt; &lt;img src="assets/imgs/J-Neyman.jpg" width="43%"/&gt;
]
.pull-left[
Sir. Ronald A. Fisher&lt;br&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;(1890 ~ 1962)
]
.pull-right[
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Egon Pearson&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Jerzy Neyman&lt;br&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;(1895 ~ 1980)&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;(1894 ~ 1981)
]



???
Sir Ronald Aylmer Fisher

í†µê³„ì  ê²€ì •ë²•ì€ K. Pearsonê³¼ W. Gossetì˜ ê²½ìš°ë¥¼ ì œ
ì™¸í•˜ê³  ë‚˜ë©´ í”íˆâ€˜ìœ ì˜ì„±ê²€ì • (significance test)â€™ì´ë¼ê³  ë¶ˆë¦¬ëŠ” Fisherì˜ ê²€ì •ë²•ê³¼â€˜ê°€
ì„¤ê²€ì • (hypotheses test)â€™ì´ë¼ê³  ë¶ˆë¦¬ëŠ” Neyman-Pearsonì˜ ê²€ì •ë²•ì´ ë“±ì¥í•œ 1920â€“
1930ë…„ëŒ€ë¶€í„° ì‹œì‘ëœë‹¤.

1925ë…„ì—ëŠ” Fisherì˜ ì±… Statistical Methods for Research Workersë¥¼ í†µí•´ ìœ ì˜ì„±ê²€ì •
(test of significance)ì´ ì²˜ìŒ ì†Œê°œë˜ì—ˆê³  ì´ì–´ì„œ 1928ë…„ê³¼ 1933ë…„ì— Neyman-Pearson
ì˜ ê°€ì„¤ê²€ì • (test of hypotheses) ì—°êµ¬ê°€ ë‚˜ì™”ë‹¤


---

# &lt;img src="assets/icons/creativity.svg" width="6%"/&gt; Motivation of Fisher

## &lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M127.1 146.5c1.3 7.7 8 13.5 16 13.5h16.5c9.8 0 17.6-8.5 16.3-18-3.8-28.2-16.4-54.2-36.6-74.7-14.4-14.7-23.6-33.3-26.4-53.5C111.8 5.9 105 0 96.8 0H80.4C70.6 0 63 8.5 64.1 18c3.9 31.9 18 61.3 40.6 84.4 12 12.2 19.7 27.5 22.4 44.1zm112 0c1.3 7.7 8 13.5 16 13.5h16.5c9.8 0 17.6-8.5 16.3-18-3.8-28.2-16.4-54.2-36.6-74.7-14.4-14.7-23.6-33.3-26.4-53.5C223.8 5.9 217 0 208.8 0h-16.4c-9.8 0-17.5 8.5-16.3 18 3.9 31.9 18 61.3 40.6 84.4 12 12.2 19.7 27.5 22.4 44.1zM400 192H32c-17.7 0-32 14.3-32 32v192c0 53 43 96 96 96h192c53 0 96-43 96-96h16c61.8 0 112-50.2 112-112s-50.2-112-112-112zm0 160h-16v-96h16c26.5 0 48 21.5 48 48s-21.5 48-48 48z"&gt;&lt;/path&gt;&lt;/svg&gt; The Lady Tasting Tea

.pull-left[&lt;img src="assets/imgs/tasting-tea.jpg" width="95%"/&gt;]
.pull-right[

### Is the lady possible to distinguish all sequences for making tea? 

### **The birth of Test of Significance**

]


&lt;br&gt;
&lt;br&gt;

--

## That is, a famous **Fisher's Exact Test**




???

í†µê³„í•™ì˜ ê¸°í‹€ì´ ë‹¤ì ¸ì§€ë˜ ë¬´ë µ ì˜êµ­ì˜ í•œ ê·€ë¶€ì¸ì€ ë°€í¬í™ì°¨ì˜ ë§›ë§Œ ë³´ê³  ìš°ìœ ì™€ ì°¨ë¥¼ ë”°ë¥¸ ìˆœì„œë¥¼ êµ¬ë¶„í•  ìˆ˜ ìˆë‹¤ê³  ì£¼ì¥í•˜ì˜€ë‹¤. 
ì´ë¥¼ ë¯¿ì§€ ì•Šì•˜ë˜ í”¼ì…”ëŠ” ê·€ë¬´ê°€ì„¤ì„ ì„¤ì •í•˜ê³  ì´ë¥¼ ì¦ëª…í•˜ëŠ” ì‹¤í—˜ì„ ì¤€ë¹„í•œë‹¤. 
ìš°ìœ ì™€ ì°¨ë¥¼ ë‹¤ë¥¸ ìˆœì„œë¡œ ë”°ë¥¸ í™ì°¨ë¥¼ 4ê°œì”© ì¤€ë¹„í•˜ì—¬ ì´ 8ê°œë¥¼ ë¬´ì‘ìœ„ì˜ ìˆœì„œë¡œ ê·€ë¶€ì¸ì—ê²Œ ë§›ë³´ê²Œ í•œ ë’¤ ë‹µì„ ë§í•˜ê²Œ í•˜ì˜€ë‹¤. 
ì„¤ê³„ê°€ í—ˆë§í•˜ê²Œ ê·€ë¶€ì¸ì€ ì°¨ë¥¼ ë§Œë“  ìˆœì„œë¥¼ ëª¨ë‘ ë§ì¶”ì—ˆë‹¤. 
í•˜ì§€ë§Œ í”¼ì…”ëŠ” â€˜ì°¨ ë§ˆì‹œëŠ” ì—¬ì¸â€™ì˜ ë¬¸ì œë¥¼ í†µí•´ ê·€ë¬´ê°€ì„¤ê³¼ ë¬´ì‘ìœ„ë¥¼ ì´ìš©í•œ ê°€ì„¤ ê²€ì •ê¸°ë²•ì„ ì œì‹œí•œë‹¤

---


# &lt;img src="assets/icons/compare.svg" width="6%"/&gt; Comparisons


#### **RA. Fisher** `\(\rightarrow\)` (_Inductive Inference_)

&gt; - Set **only** the null hypothesis `\(H_{0}\)`
&gt; - Derive a **p-value** from the data
&gt; - If the obtained p-value is **sufficiently small**, then
data can be redarded as the statistically significant result


#### **Neyman and E. Pearson** `\(\rightarrow\)` (_Inductive Behaviour_)

&gt; - Set **both** null `\((H_{0})\)` and alternative `\((H_{1})\)`
&gt; - Select the **test statistics** and the **region of rejection** 
satisfying the maximum power under the given significance level `\(\alpha\)`
&gt; - Obtain the **test statistics** from the given data
&gt; - If an obtained test statistics fell into the region of rejection, 
then accept `\(H_{1}\)`; Otherwise accept `\(H_{0}\)`


###&lt;svg viewBox="0 0 448 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M313.941 216H12c-6.627 0-12 5.373-12 12v56c0 6.627 5.373 12 12 12h301.941v46.059c0 21.382 25.851 32.09 40.971 16.971l86.059-86.059c9.373-9.373 9.373-24.569 0-33.941l-86.059-86.059c-15.119-15.119-40.971-4.411-40.971 16.971V216z"&gt;&lt;/path&gt;&lt;/svg&gt; Today, **HYBRID** both paradigms


???

Fisher


p ê°’ì˜ í¬ê¸°ë¡œ â€˜ê·¼ê±°ì˜ ê°•ë„(strength of evidence)â€™ë¥¼ íŒë‹¨.

ê²€ì •ê²°ê³¼ê°€ ìœ ì˜í•˜ë©´ H0 ê°€ í‹€ë ¸ê±°
ë‚˜ ë‚˜ì˜¤ê¸° ì–´ë ¤ìš´ ê²°ê³¼ê°€ ë‚˜ì™”ë‹¤ê³ 
íŒë‹¨í•˜ê³  ì¶”ë¡ ì„ ê³„ì†í•œë‹¤.

H0 ë¥¼ ë°˜ì¦(disprove)í•  ìˆ˜ëŠ” ìˆìœ¼ë‚˜ ì¦ëª…í•˜ê±°ë‚˜ ì±„íƒí•  ìˆ˜ëŠ” ì—†ë‹¤.
ê²€ì •ì˜ ê²°ê³¼ëŠ” ì„ì‹œì ì¸ ê²ƒìœ¼ë¡œì„œ ë‹¤ì‹œ ê³ ì¹  ìˆ˜ ìˆì–´ì•¼í•œë‹¤.
ê²€ì •í†µê³„ëŸ‰ì„ ì„ì˜ë¡œ ì„ íƒí•œë‹¤. ìµœì ê²€ì •ë²• (optimal test) ë¼ëŠ” ë³´ì¥ì´ ì—†ë‹¤.
ìœ ì˜í•œ ê²°ê³¼ê°€ ë‚˜ì™€ë„ H1 ì´ ì—†ìœ¼ë¯€ë¡œ êµ¬ì²´ì ì¸ ê²°ë¡ ì„ ë‚´ë¦´ ìˆ˜ ì—†
ë‹¤. ìœ ì˜í•œ ê²°ê³¼ê°€ ë‚˜ì˜¤ì§€ ì•Šìœ¼ë©´ ê²°ë¡ ì€ ë”ìš± ëª¨í˜¸í•˜ë‹¤.

P-Neyman

í™•ë¥ ì— ë°”íƒ•ì„ ë‘” ê²€ì •ì€ ê°€ì„¤ì˜ ì°¸ê³¼ ê±°ì§“ì— ëŒ€í•œ ì •ë³´ë¥¼ ì œê³µí•  ìˆ˜
ì—†ë‹¤. ë™ì¼í•œ ê²€ì •ì„ ë°˜ë³µí•  ë•Œ ì˜ëª»ëœ ê²°ê³¼ê°€ ë‚˜ì˜¬ ì˜¤ë¥˜ì˜ í™•ë¥ ì„
ê°€ì§€ê³  ìµœì ì˜ ê²€ì •ë²•ì„ ì°¾ì•„ ë‘ ê°€ì„¤ ê°€ìš´ë° í•˜ë‚˜ë¥¼ ì„ íƒí•œë‹¤.

ì œí’ˆì˜ í•©ê²©-ë¶ˆí•©ê²© íŒì •ì„ í•  ë•Œì—ë‚˜ ì“¸ ìˆ˜ ìˆëŠ” ê²ƒìœ¼ë¡œì„œ ì¼ë°˜ì ì¸ 
ê³¼í•™ ì—°êµ¬ì—ì„œì˜ ì¶”ë¡  ë°©ë²•ìœ¼ë¡œì ì ˆí•˜ì§€ ì•Šë‹¤.
í˜„ì‹¤ì ì¸ ê³¼í•™ì‹¤í—˜ì—ì„œëŠ” ë™ì¼í•œ ê²€ì •ì„ ë°˜ë³µí•´ì„œ ì–»ëŠ” í™•ë¥ ì˜ ê°œë…
ì´ íƒ€ë‹¹í•˜ì§€ ì•Šë‹¤.

---


# The Statistical Inference Today

&lt;br&gt;

.center[&lt;img src="assets/imgs/stat-infer-scheme.png" width="90%"&gt;]


.center[##### Schematic relationship between population, sample, statistic, and sampling distribution]



---

# Exact Meaning of the P-value

##  &lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M256 8C119.043 8 8 119.083 8 256c0 136.997 111.043 248 248 248s248-111.003 248-248C504 119.083 392.957 8 256 8zm0 110c23.196 0 42 18.804 42 42s-18.804 42-42 42-42-18.804-42-42 18.804-42 42-42zm56 254c0 6.627-5.373 12-12 12h-88c-6.627 0-12-5.373-12-12v-24c0-6.627 5.373-12 12-12h12v-64h-12c-6.627 0-12-5.373-12-12v-24c0-6.627 5.373-12 12-12h64c6.627 0 12 5.373 12 12v100h12c6.627 0 12 5.373 12 12v24z"&gt;&lt;/path&gt;&lt;/svg&gt; Definition


&gt; The probability, **under the assumption of the null hypothesis**, of 
obtaining a result equal to or more extreme than what was **actually observed**. 


### Interpretation

&gt; `\(P = 0.5\)` : Under the `\(H_{0}\)`, values greater or less than a statistic obtained from the given data is observed
about once in the two times `\(\rightarrow\)` insufficient to reject `\(H_{0}\)`
&gt;
&gt; `\(P = 0.000001\)` : Under the `\(H_{0}\)`, it is almost impossible to observe such values as extreme as the data given 
`\(\rightarrow\)` sufficient to reject `\(H_{1}\)`


### How about 

&gt; Assume an RCT to investigate the efficacy of the treatment drug and obtain the result of `\(P=0.108\)`. 
&gt;
&gt; What is your interpretation of the result?


???

ìš°ë¦¬ê°€ ì–»ì€ ë°ì´í„°ë¡œë¶€í„° ë„ì¶œí•œ í†µê³„ëŸ‰ë§Œí¼ì˜ ê°’ì„ ê·€ë¬´ê°€ì„¤ í•˜ì—ì„œ ê´€ì°°í•  í™•ë¥  

p=0.5 ì´ë©´ ë‘ ë²ˆì— í•œë²ˆ ê¼´ë¡œ ìš°ë¦¬ê°€ í‘œë³¸ìœ¼ë¡œë¶€í„° íšë“í•œ í†µê³„ëŸ‰ì„ ê·€ë¬´ê°€ì„¤ í•˜ì˜ ë¶„í¬ì—ì„œ ê´€ì°°í•  ìˆ˜ ìˆìŒ
p=0.0000001 ì´ë©´ ë§¤ìš° ë‚®ì€ í™•ë¥ ë¡œ ìš°ë¦¬ê°€ ì–»ì€ í†µê³„ëŸ‰ì´ ê·€ë¬´ê°€ì„¤ í•˜ì˜ ë¶„í¬ì—ì„œ ê´€ì°°ë¨. ì¦‰ ê±°ì˜ ê´€ì°°ë˜ì§€ ì•ŠìŒ. 
ê·€ë¬´ê°€ì„¤ì„ ê¸°ê°í•¨. 



---

# &lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8zm115.7 272l-176 101c-15.8 8.8-35.7-2.5-35.7-21V152c0-18.4 19.8-29.8 35.7-21l176 107c16.4 9.2 16.4 32.9 0 42z"&gt;&lt;/path&gt;&lt;/svg&gt; Playing with P-values

## &lt;img src="assets/icons/simulation.svg" width="5%"/&gt; Simulation

### Scenario 1: `\(H_{0}\)` is true


&gt;- Suppose `\(X \sim \mathcal{N}(\mu_{X}, \sigma^{2}_{X})\)` and `\(Y \sim \mathcal{N}(\mu_{Y}, \sigma^{2}_{Y})\)`
&gt;
&gt;- Assume that `\(\mu_{X}=\mu_{Y}=100\)` and `\(\sigma_{X}=\sigma_{Y}=20\)`
&gt;
&gt;- Obtain the p-value from the independent two-sample t-test based on 100 samples independently extracted from the distribution of `\(X\)` and `\(Y\)`. 
&gt;
&gt;- Experiment 100,000 times

---

# &lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8zm115.7 272l-176 101c-15.8 8.8-35.7-2.5-35.7-21V152c0-18.4 19.8-29.8 35.7-21l176 107c16.4 9.2 16.4 32.9 0 42z"&gt;&lt;/path&gt;&lt;/svg&gt; Playing with P-values

### Scenario 1: Result


&lt;img src="Figures/p-val-sim1-1.svg" width="70%" style="display: block; margin: auto;" /&gt;


&gt; - Even if no true difference b/w `\(X\)` and `\(Y\)` `\(\rightarrow\)` 5.1 % of p-values `\(&lt; 0.05\)`
&gt; - Even if `\(X\)` and `\(Y\)` are identically distributed `\(\rightarrow\)` 4.9 % `\(&gt; 0.95\)`

---

# &lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8zm115.7 272l-176 101c-15.8 8.8-35.7-2.5-35.7-21V152c0-18.4 19.8-29.8 35.7-21l176 107c16.4 9.2 16.4 32.9 0 42z"&gt;&lt;/path&gt;&lt;/svg&gt; Playing with P-values

## &lt;img src="assets/icons/simulation.svg" width="5%"/&gt; Simulation

### Scenario 2: small difference between `\(X\)` and `\(Y\)`


&gt; - Suppose `\(X \sim \mathcal{N}(\mu_{X}, \sigma^{2}_{X})\)` and `\(Y \sim \mathcal{N}(\mu_{Y}, \sigma^{2}_{Y})\)`
&gt; 
&gt; - `\(\mu_{X} = 100\)`, `\(\mu_{Y} = 102\)` 
&gt; 
&gt; - `\(\sigma_{X}=\sigma_{Y}=20\)`
&gt; 
&gt; - Increasing sample size 30, 100, 200, 400, 1000 and obtaining P-values resulted from independent two sample t-tests
&gt; 
&gt; - Experiment 10,000 times


---



# &lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8zm115.7 272l-176 101c-15.8 8.8-35.7-2.5-35.7-21V152c0-18.4 19.8-29.8 35.7-21l176 107c16.4 9.2 16.4 32.9 0 42z"&gt;&lt;/path&gt;&lt;/svg&gt; Playing with P-values

### Scenario 2: Result





&lt;img src="Figures/p-val-sim2-1.svg" width="70%" style="display: block; margin: auto;" /&gt;

&gt; Increasing sample size `\(\rightarrow\)` % of `\(P &lt; 0.05\)` increase

---
# &lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8zm115.7 272l-176 101c-15.8 8.8-35.7-2.5-35.7-21V152c0-18.4 19.8-29.8 35.7-21l176 107c16.4 9.2 16.4 32.9 0 42z"&gt;&lt;/path&gt;&lt;/svg&gt; Playing with P-values

## &lt;img src="assets/icons/simulation.svg" width="5%"/&gt; Simulation

### Scenario 3: Large Effect Size 


&gt; - Suppose `\(X \sim \mathcal{N}(\mu_{X}, \sigma^{2}_{X})\)` and `\(Y \sim \mathcal{N}(\mu_{Y}, \sigma^{2}_{Y})\)`
&gt; 
&gt; - `\(\mu_{X} = 100\)`, `\(\mu_{Y} = 116\)` 
&gt; 
&gt; - `\(\sigma_{X}=\sigma_{Y}=20\)`
&gt;
&gt; - True effect size `\(\delta=0.8\)`
&gt;
&gt; - Identical number of samples and experiments to the scenario 1 except for the sample size `\(n = 33\)`


---

# &lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8zm115.7 272l-176 101c-15.8 8.8-35.7-2.5-35.7-21V152c0-18.4 19.8-29.8 35.7-21l176 107c16.4 9.2 16.4 32.9 0 42z"&gt;&lt;/path&gt;&lt;/svg&gt; Playing with P-values

### Scenario 3: Result


&lt;img src="Figures/p-val-sim3-1.svg" width="75%" style="display: block; margin: auto;" /&gt;


&gt; - Effect size `\(\delta\)` converged to the true difference 16
&gt; - % of `\(P &lt; 0.05\)` = 89.2 `\(\approx\)` 90 % `\(\rightarrow\)` **statistical POWER**




---
# &lt;svg viewBox="0 0 384 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M336 64h-80c0-35.3-28.7-64-64-64s-64 28.7-64 64H48C21.5 64 0 85.5 0 112v352c0 26.5 21.5 48 48 48h288c26.5 0 48-21.5 48-48V112c0-26.5-21.5-48-48-48zM192 40c13.3 0 24 10.7 24 24s-10.7 24-24 24-24-10.7-24-24 10.7-24 24-24zm121.2 231.8l-143 141.8c-4.7 4.7-12.3 4.6-17-.1l-82.6-83.3c-4.7-4.7-4.6-12.3.1-17L99.1 285c4.7-4.7 12.3-4.6 17 .1l46 46.4 106-105.2c4.7-4.7 12.3-4.6 17 .1l28.2 28.4c4.7 4.8 4.6 12.3-.1 17z"&gt;&lt;/path&gt;&lt;/svg&gt;  Guidlines 

### &lt;img src="assets/icons/statement.svg" width="4%"/&gt; ASA's statement on p-values (Wasserstein, Lazar, and others, 2016)

&gt; 1. indicating **incompatible the data are with a specified statistical model**. 
&gt;
&gt; 2. **NOT MEASURE THE PROBABILITY**: the studied hypothesis is **true**, the data were produced by
random chance alone.
&gt;
&gt; 3. **DO NOT MAKE CONCLUSIONS**: based only on whether a p-value passes a specific threshold 
`\(\rightarrow\)` don't use `\(p &lt; 0.05\)` and **\*\***, something like that
&gt;
&gt; 4. **Do full reporting and transparency**
&gt;
&gt; 5. **NOT MEASURE** the size of an effect or the importance of a result
&gt;
&gt; 6. **NOT ** a good measure of **EVIDENCE**


???

1. ìœ ì˜ì„±ë§Œ ë³´ê³ 
2. ëª¨ìˆ˜ì— ëŒ€í•œ í™•ë¥ ì´ ì•„ë‹˜
3. ë†’ì€ Pê°’ì´ ê·€ë¬´ê°€ì„¤ì´ ì˜³ë‹¤ëŠ” ì¦ê±°ë¡œ ì‚¬ìš©ë˜ëŠ” ì˜¤ë¥˜
   - ì¦ê±°ì˜ ë¶ˆì¶©ë¶„í•¨ì„ ì˜ë¯¸í•¨  
   - ê·€ë¬´ê°€ì„¤ì˜ ì˜³ê³ ê·¸ë¦„ì„ ì¦ëª…í•˜ëŠ” ê²ƒì€ ë¶ˆê°€ëŠ¥ 
   H0: ë‘ ì§‘ë‹¨ ê°„ í‰ê·  ì°¨ì´ê°€ ì—†ë‹¤ë©´ íš¨ê³¼ê°€ ì—†ë‹¤ 
   H1: ë‘ ì§‘ë‹¨ ê°„ í‰ê·  ì°¨ì´ê°€ ìˆë‹¤ë©´ íš¨ê³¼ê°€ ìˆë‹¤
   
ê·€ë¬´ê°€ì„¤ì— ëŒ€í•œ ëŒ€ìš°ëª…ì œëŠ” íš¨ê³¼ê°€ ì—†ë‹¤ë©´ ë‘ ì§‘ë‹¨ ê°„ í‰ê·  ì°¨ì´ê°€ ìˆë‹¤ì„

4. ë‚®ì€ P-ê°’ì´ í•­ìƒ ì˜ë¯¸ê°€ ìˆë‹¤ê³  ì´í•´í•˜ëŠ” ì˜¤ë¥˜
5. ì‹ ë¢°êµ¬ê°„ì„ ë¬´ì‹œ

1. P-values can indicate how incompatible the data are with a
specified statistical model.
2. P-values do not measure the probability that the studied
hypothesis is true, or the probability that the data were produced by
random chance alone.
3. Scientific conclusions and business or policy decisions should not be
based only on whether a p-value passes a specific threshold.
4. Proper inference requires full reporting and transparency.
5. A p-value, or statistical significance, does not measure the size of
an effect or the importance of a result.
6. By itself, a p-value does not provide a good measure of
evidence regarding a model or hypothesis.



---

class: inverse, center, middle

# &lt;svg viewBox="0 0 496 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M248 8C111 8 0 119 0 256s111 248 248 248 248-111 248-248S385 8 248 8zm80 168c17.7 0 32 14.3 32 32s-14.3 32-32 32-32-14.3-32-32 14.3-32 32-32zm-160 0c17.7 0 32 14.3 32 32s-14.3 32-32 32-32-14.3-32-32 14.3-32 32-32zm194.8 170.2C334.3 380.4 292.5 400 248 400s-86.3-19.6-114.8-53.8c-13.6-16.3 11-36.7 24.6-20.5 22.4 26.9 55.2 42.2 90.2 42.2s67.8-15.4 90.2-42.2c13.4-16.2 38.1 4.2 24.6 20.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M377.941 169.941V216H134.059v-46.059c0-21.382-25.851-32.09-40.971-16.971L7.029 239.029c-9.373 9.373-9.373 24.568 0 33.941l86.059 86.059c15.119 15.119 40.971 4.411 40.971-16.971V296h243.882v46.059c0 21.382 25.851 32.09 40.971 16.971l86.059-86.059c9.373-9.373 9.373-24.568 0-33.941l-86.059-86.059c-15.119-15.12-40.971-4.412-40.971 16.97z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;svg viewBox="0 0 496 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M248 8C111 8 0 119 0 256s111 248 248 248 248-111 248-248S385 8 248 8zm80 168c17.7 0 32 14.3 32 32s-14.3 32-32 32-32-14.3-32-32 14.3-32 32-32zm-160 0c17.7 0 32 14.3 32 32s-14.3 32-32 32-32-14.3-32-32 14.3-32 32-32zm170.2 218.2C315.8 367.4 282.9 352 248 352s-67.8 15.4-90.2 42.2c-13.5 16.3-38.1-4.2-24.6-20.5C161.7 339.6 203.6 320 248 320s86.3 19.6 114.7 53.8c13.6 16.2-11 36.7-24.5 20.4z"&gt;&lt;/path&gt;&lt;/svg&gt; Minimally Clinically Important Difference 


---

# &lt;svg viewBox="0 0 512 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M256 8C119.043 8 8 119.083 8 256c0 136.997 111.043 248 248 248s248-111.003 248-248C504 119.083 392.957 8 256 8zm0 110c23.196 0 42 18.804 42 42s-18.804 42-42 42-42-18.804-42-42 18.804-42 42-42zm56 254c0 6.627-5.373 12-12 12h-88c-6.627 0-12-5.373-12-12v-24c0-6.627 5.373-12 12-12h12v-64h-12c-6.627 0-12-5.373-12-12v-24c0-6.627 5.373-12 12-12h64c6.627 0 12 5.373 12 12v100h12c6.627 0 12 5.373 12 12v24z"&gt;&lt;/path&gt;&lt;/svg&gt; Definition 

### In Origin (MCID)

&gt; **"_The smallest difference in score in the domain of interest which patients perceive as 
beneficial and which would mandate, in the absence of troublesome side effects and 
excessive cost, a change in the patient's management_"**
&gt;  _(Jaeschke, Singer, and Guyatt, 1989)_


### Focusing on Patients: Minimal Imporant Change (MID)

&gt; **"__the smallest difference in score in the outcome of interest that informed patients or
informed proxies perceive as important, either beneficial or harmful, and that would
lead the patient or clinician to consider a change in the management__"**
&gt; _(SchÃ¼nemann, Puhan, Goldstein, Jaeschke, and Guyatt, 2005)_


### In Simple

&gt; **"_the smallest (minimal amount of) change that is important to patients_"**
&gt; _(Copay, Subach, Glassman, Polly Jr, and Schuler, 2007)_



???

í™˜ì ì¤‘ì‹¬ì˜ ì§„ë£Œ(patient-centered care)ê°€ ê°•ì¡°ë˜ë©´ì„œ í™˜ìì˜ ì£¼ê´€ì  ì‚¶ì˜ ì§ˆ ë˜ëŠ” ê²½í—˜
ì´ ì ì°¨ ì¤‘ìš”í•´ì¡Œê³ , ì´ì— ë”°ë¼ ë‹¤ì–‘í•œ ì—°êµ¬ì—ì„œ ê°ì¢… HRQoL ë˜ëŠ” PRO ë„êµ¬ê°€ ì¤‘ìš”í•œ ì¸¡ì •
ë„êµ¬ë¡œ í™œìš©ë˜ê³  ìˆë‹¤(Wyrwich, 2004; Wyrwich et al., 2013). ê·¸ëŸ¬ë‚˜ PROëŠ” í›ˆë ¨ë°›ì€ ì„ìƒ
ì „ë¬¸ê°€ê°€ ì•„ë‹Œ í™˜ìì˜ í‰ê°€ë¥¼ í†µí•´ ì‚°ì¶œë˜ê¸° ë•Œë¬¸ì—, ì´ì— ëŒ€í•œ í•´ì„ì˜ ì–´ë ¤ì›€ì´ ë”°ë¥¸ë‹¤. 
ì¦‰, PRO ë„êµ¬ë¡œ ì¸¡ì •ëœ ì ìˆ˜ ë³€í™”ê°€ ê³¼ì—° ì˜ë¯¸ ìˆëŠ” ë³€í™”ì¸ì§€ ë˜ëŠ” í™˜ì ê´€ë¦¬ë¥¼ ë‹¤ë¥¸ ë°©ì‹ìœ¼ë¡œ
ë³€ê²½í•´ì•¼ í•  ì •ë„ì˜ ë³€í™”ì¸ì§€ ë“±ì„ íŒë‹¨í•˜ê¸°ê°€ ì‰½ì§€ ì•Šë‹¤. í†µê³„ì  ìœ ì˜ì„±ì„ ê·¼ê±°ë¡œ íŒë‹¨í•˜ëŠ”
ë°©ë²•ë„ ìˆìœ¼ë‚˜, í†µê³„ì  ìœ ì˜ì„±ì€ í‘œë³¸ í¬ê¸°ì— ë”°ë¼ ì‘ì€ ì°¨ì´ì—ë„ ìœ ì˜í•˜ê²Œ ë‚˜ì˜¤ê±°ë‚˜ í° ì°¨
ì´ì—ë„ ìœ ì˜í•˜ì§€ ì•Šê²Œ ë‚˜ì˜¬ ìˆ˜ ìˆë‹¤. ë”°ë¼ì„œ í†µê³„ì  ìœ ì˜ì„±ë§Œìœ¼ë¡œ ì„ìƒì  ìœ ì˜ì„±ì„ íŒë‹¨í•˜ëŠ”
ë°ì—ëŠ” í•œê³„ê°€ ìˆë‹¤. ì´ì— ëŒ€í•œ ëŒ€ì•ˆìœ¼ë¡œ í™˜ìì—ê²Œ ì¤‘ìš”í•œ PRO ë³€í™”ê°€ ì–´ëŠ ìˆ˜ì¤€ì¸ì§€ íŒŒì•…
í•˜ê¸° ìœ„í•œ ì²´ê³„ì  ì‹œë„ê°€ ì´ë¤„ì¡ŒëŠ”ë°, íŠ¹íˆ ìºë‚˜ë‹¤ McMaster ëŒ€í•™êµ ì—°êµ¬ì§„ë“¤ì„ ì¤‘ì‹¬ìœ¼ë¡œ
ê´€ë ¨ ì—°êµ¬ê°€ í™œë°œí•˜ê²Œ ìˆ˜í–‰ë˜ì—ˆë‹¤. ì´ ì—°êµ¬ì§„ë“¤ì€â€˜ìµœì†Œí•œì˜ ì„ìƒì ìœ¼ë¡œ ì˜ë¯¸ ìˆëŠ” ì°¨
ì´â€™(minimal clinically important difference, MCID)ì— ëŒ€í•œ ê¸°ì¤€ì„ ì œê³µí•˜ê³ ì ë…¸ë ¥í•˜ì˜€ëŠ”ë°,
Jaeschke et al. (1989)ì€ MCIDë¥¼ ë‹¤ìŒê³¼ ê°™ì´ ê³µì‹ì ìœ¼ë¡œ ì •ì˜í•˜ì˜€ë‹¤.

 ì´ ì •ì˜ì— ë”°ë¥´ë©´ MCIDëŠ” í™˜ìê°€ ì´ìµ(beneficial)ìœ¼ë¡œ ì¸ì‹í•˜ê³ , (ë²ˆê±°ë¡œìš´ ë¶€ì‘ìš©ì´ë‚˜ ê³¼
ë„í•œ ë¹„ìš©ì´ ë°œìƒí•˜ì§€ ì•Šì•„ë„) í™˜ì ê´€ë¦¬ì— ë³€í™”ê°€ í•„ìš”í•  ìˆ˜ ìˆëŠ” ê´€ì‹¬ ì˜ì—­ì—ì„œì˜ ê°€ì¥ ì‘
ì€ ì ìˆ˜ ì°¨ì´ë¥¼ ì˜ë¯¸í•œë‹¤. ê·¸ëŸ¬ë‚˜ â€˜ì„ìƒì (clinical)â€™ì´ë€ ìš©ì–´ê°€ í™˜ì ì¼ìƒ ê²½í—˜ë³´ë‹¤ëŠ” ì„
ìƒ ì˜ì—­(clinical arena)ì— ë” ì´ˆì ì„ ë§ì¶”ëŠ” ê²½í–¥ì´ ìˆë‹¤ëŠ” ì£¼ì¥ì´ ì œê¸°ë˜ì–´(SchÃ¼nemann et
al., 2005a), ì´í›„ ê°™ì€ ì—°êµ¬íŒ€ì—ì„œëŠ” â€˜ì„ìƒì â€™ì´ë¼ëŠ” ìš©ì–´ë¥¼ ì œì™¸í•œ â€˜ìµœì†Œí•œì˜ ì˜ë¯¸ ìˆëŠ”
ì°¨ì´â€™(minimal important difference, MID)ë¥¼ ì‚¬ìš©í•˜ê¸° ì‹œì‘í–ˆë‹¤(Juniper et al., 1994;
SchÃ¼nemann et al., 2005b). SchÃ¼nemann et al.(2005b)ì€ MIDë¥¼ ë‹¤ìŒê³¼ ê°™ì´ ê³µì‹ì ìœ¼ë¡œ ì¬ì •
ì˜í•˜ì˜€ë‹¤. 

ì¦‰, MIDëŠ” í™˜ì(informed patients) ë˜ëŠ” ëŒ€ë¦¬ì(informed proxies)ê°€ ì¤‘ìš”í•˜ë‹¤ê³ , ì¦‰ ì´ìµ
ì´(beneficial) ë˜ê±°ë‚˜ í•´ë¡­ë‹¤ê³ (harmful) ì¸ì‹í•˜ê³ , í™˜ìë‚˜ ì„ìƒì˜ê°€ ê´€ë¦¬ì— ë³€í™”ë¥¼ ê³ ë ¤í•˜ë„
ë¡ ë§Œë“¤ ìˆ˜ ìˆëŠ” ê´€ì‹¬ ê²°ê³¼(outcome of interest)ì—ì„œì˜ ê°€ì¥ ì‘ì€ ì ìˆ˜ ì°¨ì´ë¥¼ ì˜ë¯¸í•œë‹¤. ì´
ì™¸ì—ë„ ê°ì§€í•  ìˆ˜ ìˆëŠ” ìµœì†Œ ë³€í™”(minimum detectable change, MDC), ê°ì§€í•  ìˆ˜ ìˆëŠ” ê°€ì¥
ì‘ì€ ì°¨ì´(smallest detectable difference) ë“± ë‹¤ì–‘í•œ ìš©ì–´ê°€ í˜¼í•©ë˜ì–´ ì‚¬ìš©ë˜ê³  ìˆë‹¤. ì—¬ê¸°ì„œ
ëŠ” í˜¸ì£¼ PBAC ì§€ì¹¨ì—ì„œì™€ ë§ˆì°¬ê°€ì§€ë¡œ MCIDë¼ëŠ” ìš©ì–´ë¡œ í†µì¹­í•˜ì—¬ ì‚¬ìš©í•˜ì˜€ìœ¼ë©°, ìš©ì–´ì— ëŒ€
í•œ ì •ì˜ ë° ë³€ì²œì‚¬ëŠ” King et al.(2011) ë“±ì˜ ë‹¤ë¥¸ ì—°êµ¬ë¥¼ ì°¸ì¡°í•  ìˆ˜ ìˆë‹¤. 


---

# How to Obtain M(C)ID? 

&lt;br&gt;

## 1. **Anchor-based methods**

&lt;br&gt;&lt;br&gt;

## 2. **Distribution-based methods**


&lt;br&gt;&lt;br&gt;

## 3. Delphi method (_skip_)


&lt;br&gt;&lt;br&gt;



???

ê·¸ ì™¸ ë„êµ¬ì •ì˜ ì ‘ê·¼ë²•
ëˆ„ì ë¶„í¬ë²• -&gt; ë„êµ¬ì ìˆ˜ì˜ ë³€í™”ë¥¼ Xì¶•ìœ¼ë¡œ í•´ì„œ ì´ ì ìˆ˜ ë³€í™”ë¥¼ cut-off ì‚¬ìš© ì‹œ responder ë¹„ìœ¨ì„ Yì— ì œì‹œ

---

# &lt;svg viewBox="0 0 576 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M12.971 352h32.394C67.172 454.735 181.944 512 288 512c106.229 0 220.853-57.38 242.635-160h32.394c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0l-67.029 67.029c-7.56 7.56-2.206 20.485 8.485 20.485h35.146c-20.29 54.317-84.963 86.588-144.117 94.015V256h52c6.627 0 12-5.373 12-12v-40c0-6.627-5.373-12-12-12h-52v-5.47c37.281-13.178 63.995-48.725 64-90.518C384.005 43.772 341.605.738 289.37.01 235.723-.739 192 42.525 192 96c0 41.798 26.716 77.35 64 90.53V192h-52c-6.627 0-12 5.373-12 12v40c0 6.627 5.373 12 12 12h52v190.015c-58.936-7.399-123.82-39.679-144.117-94.015h35.146c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0L4.485 331.515C-3.074 339.074 2.28 352 12.971 352zM288 64c17.645 0 32 14.355 32 32s-14.355 32-32 32-32-14.355-32-32 14.355-32 32-32z"&gt;&lt;/path&gt;&lt;/svg&gt; Anchor-based Methods 

### **Compare new PROs to the Well-Known PRO**

&gt; - Use an external criterion to define an important change 
&gt; - Compare PRO scores to the patient's answers to another subjective instrument
&gt; - typical Anchors: 
&gt;    - Global Rating of Change
&gt;    - Global Perceived Effect
&gt;    - Patients' Global Impression of Change
&gt;    - SF-36, ...
&gt; - Concerning PRO scores must show the correlation to the anchor. 


### **Disadvantages**

&gt; - **Lack of validity and reliability**
&gt; - **Too subjective**
&gt; - **Recall bias**


&lt;svg viewBox="0 0 448 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M313.941 216H12c-6.627 0-12 5.373-12 12v56c0 6.627 5.373 12 12 12h301.941v46.059c0 21.382 25.851 32.09 40.971 16.971l86.059-86.059c9.373-9.373 9.373-24.569 0-33.941l-86.059-86.059c-15.119-15.119-40.971-4.411-40.971 16.971V216z"&gt;&lt;/path&gt;&lt;/svg&gt; **_VERY SENSITIVE TO CHANGE IN BOTH NEG. AND POS._**


???

ì¤€ê±°ê¸°ë°˜ë²•. ì¤€ê±°(anchor)ê°€ ë  ìˆ˜ ìˆëŠ” ë‹¤ë¥¸ ì¸¡ì •ë„êµ¬ë¥¼ ì´ìš©í•´ MID ì¶”ì • ë°©ë²•
AnchorëŠ” MIDë¥¼ ì¶”ì •í•˜ê³ ì í•˜ëŠ” ì¸¡ì •ë„êµ¬ì™€ ìƒê´€ê´€ê³„ë¥¼ ë³´ì—¬ì•¼ë§Œ Anchorë¡œ ì‚¬ìš© ê°€ëŠ¥ 


ì¤€ê±°ê¸°ë°˜ë²•ì˜ ì£¼ìš” í•œê³„ì ìœ¼ë¡œëŠ” (1) íšŒìƒì— ê¸°ë°˜í•œ ì¤€ê±° ì´ìš© ì‹œ íšŒìƒ ë¹„ëš¤ë¦¼(recall bias)
ì´ ë°œìƒí•  ìˆ˜ ìˆê³ , (2) ì–´ë–¤ ì¤€ê±° ë„êµ¬ë¥¼ ì‚¬ìš©í–ˆëŠëƒì— ë”°ë¼ ê²°ê³¼ê°€ ë‹¬ë¼ì§ˆ ìˆ˜ ìˆìœ¼ë©°, (3)
í‘œì¤€í™”ê°€ ìƒëŒ€ì ìœ¼ë¡œ ì–´ë µê³ , (4) ì¤€ê±° ë„êµ¬ë¥¼ í•¨ê»˜ ì ìš© ì‹œ ì‘ë‹µ ê³¼ì •ì—ì„œ ì¼ì¹˜í™”
(concordance)ê°€ ë°œìƒí•  ìˆ˜ ìˆëŠ” ì  ë“±ì´ ìˆë‹¤


---

# &lt;svg viewBox="0 0 576 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M12.971 352h32.394C67.172 454.735 181.944 512 288 512c106.229 0 220.853-57.38 242.635-160h32.394c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0l-67.029 67.029c-7.56 7.56-2.206 20.485 8.485 20.485h35.146c-20.29 54.317-84.963 86.588-144.117 94.015V256h52c6.627 0 12-5.373 12-12v-40c0-6.627-5.373-12-12-12h-52v-5.47c37.281-13.178 63.995-48.725 64-90.518C384.005 43.772 341.605.738 289.37.01 235.723-.739 192 42.525 192 96c0 41.798 26.716 77.35 64 90.53V192h-52c-6.627 0-12 5.373-12 12v40c0 6.627 5.373 12 12 12h52v190.015c-58.936-7.399-123.82-39.679-144.117-94.015h35.146c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0L4.485 331.515C-3.074 339.074 2.28 352 12.971 352zM288 64c17.645 0 32 14.355 32 32s-14.355 32-32 32-32-14.355-32-32 14.355-32 32-32z"&gt;&lt;/path&gt;&lt;/svg&gt; Anchor-based Methods 


### **Regression Approach**

&gt; - `\(\mathrm{y}\)`: `\(n \times 1\)` response vector representing the change in PRO score 
&gt; - `\(\mathrm{X}\)`: `\(n\times k\)` matrix representing the **anchor** as continuous or dummy variable (dichotomized, or categorized)
&gt; - `\(\mathrm{Z}\)`: `\(n\times l\)` matrix representing covariates (e.g. age, sex, education level, ...) 
&gt; - linear regression model `\(\rightarrow\)` OLS or GLM to estimate the regression coefficients

`$$\mathrm{y} = \mathrm{X}_{n\times k}\beta_{k\times 1} + \mathrm{Z}_{n\times l}\gamma_{l \times 1} + \epsilon$$`
&gt; - `\(\beta_{k\times 1}\)`: the regression coefficients for anchor score
&gt; - `\(\gamma_{l\times 1}\)`: the regression coefficients for covariates

#### **MCID**: the estimated regression coefficient `\(\hat{\beta}\)`


&gt; - Transform `\(\mathrm{X}\)` to the dummy variable with two categories `\(\rightarrow\)` identical to the **between patients score change**
&gt; - Can be adjustable for covariates 


???

Xì™€ Yë¥¼ ë°˜ëŒ€ë¡œ ë†“ê³  ë¡œì§€ìŠ¤í‹± íšŒê·€ëª¨í˜• ì‚¬ìš© ê°€ëŠ¥ ì´ê²½ìš° ROC ë°©ë²•ê³¼ ìœ ì‚¬

---


# &lt;svg viewBox="0 0 576 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M12.971 352h32.394C67.172 454.735 181.944 512 288 512c106.229 0 220.853-57.38 242.635-160h32.394c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0l-67.029 67.029c-7.56 7.56-2.206 20.485 8.485 20.485h35.146c-20.29 54.317-84.963 86.588-144.117 94.015V256h52c6.627 0 12-5.373 12-12v-40c0-6.627-5.373-12-12-12h-52v-5.47c37.281-13.178 63.995-48.725 64-90.518C384.005 43.772 341.605.738 289.37.01 235.723-.739 192 42.525 192 96c0 41.798 26.716 77.35 64 90.53V192h-52c-6.627 0-12 5.373-12 12v40c0 6.627 5.373 12 12 12h52v190.015c-58.936-7.399-123.82-39.679-144.117-94.015h35.146c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0L4.485 331.515C-3.074 339.074 2.28 352 12.971 352zM288 64c17.645 0 32 14.355 32 32s-14.355 32-32 32-32-14.355-32-32 14.355-32 32-32z"&gt;&lt;/path&gt;&lt;/svg&gt; Anchor-based Methods 


### **Mean Change Appraoch**

&gt; - A subgroup of patients who reported themselves to an anchor's specific score (e.g. better, or improved)
&gt; - calculate the mean change and its `\((100-\alpha)\%\)` confidence interval
&gt; - Let `\(\bar{\delta}\)` and `\(s_{\delta}\)` be the mean change and its standard deviation of the subgroup, 

`$$\bar{\delta} \pm z_{1-\alpha}\frac{s_{\delta}}{\sqrt{n}}$$` 
#### **MCID**: `\(\bar{\delta}\)` `\(\rightarrow\)` mean change in the subgroup


.center[&lt;img src="assets/imgs/mcid-anchor-mean-change.png" width="60%"&gt;]


---

# &lt;svg viewBox="0 0 576 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M12.971 352h32.394C67.172 454.735 181.944 512 288 512c106.229 0 220.853-57.38 242.635-160h32.394c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0l-67.029 67.029c-7.56 7.56-2.206 20.485 8.485 20.485h35.146c-20.29 54.317-84.963 86.588-144.117 94.015V256h52c6.627 0 12-5.373 12-12v-40c0-6.627-5.373-12-12-12h-52v-5.47c37.281-13.178 63.995-48.725 64-90.518C384.005 43.772 341.605.738 289.37.01 235.723-.739 192 42.525 192 96c0 41.798 26.716 77.35 64 90.53V192h-52c-6.627 0-12 5.373-12 12v40c0 6.627 5.373 12 12 12h52v190.015c-58.936-7.399-123.82-39.679-144.117-94.015h35.146c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0L4.485 331.515C-3.074 339.074 2.28 352 12.971 352zM288 64c17.645 0 32 14.355 32 32s-14.355 32-32 32-32-14.355-32-32 14.355-32 32-32z"&gt;&lt;/path&gt;&lt;/svg&gt; Anchor-based Methods 


### **Minimum Detectable Change (MDC) Approach**

&gt; - Smallest change considered to be above the measurement error with a given confidence level
&gt; - Use of the mean change in score in non-responders categorized by the anchor
&gt; - Let `\(\bar{\delta}_{nr}\)` and `\(s_{\delta_{nr}}\)` be the mean change and standard deviation in the non-responder group, `\(\alpha\)` : type I error

`$$\bar{\delta}_{nr} \pm z_{1-\alpha}\frac{s_{\delta_{nr}}}{\sqrt{n}}$$`

#### **MCID**: `\(\bar{\delta}_{nr} + z_{1-\alpha}s_{\delta_{nr}}(\sqrt{n})^{-1}\)` `\(\rightarrow\)` upper limit of `\((1-\alpha)\%\)` CI


.center[&lt;img src="assets/imgs/mcid-anchor-mdc.png" width="60%"&gt;]


---

# &lt;svg viewBox="0 0 576 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M12.971 352h32.394C67.172 454.735 181.944 512 288 512c106.229 0 220.853-57.38 242.635-160h32.394c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0l-67.029 67.029c-7.56 7.56-2.206 20.485 8.485 20.485h35.146c-20.29 54.317-84.963 86.588-144.117 94.015V256h52c6.627 0 12-5.373 12-12v-40c0-6.627-5.373-12-12-12h-52v-5.47c37.281-13.178 63.995-48.725 64-90.518C384.005 43.772 341.605.738 289.37.01 235.723-.739 192 42.525 192 96c0 41.798 26.716 77.35 64 90.53V192h-52c-6.627 0-12 5.373-12 12v40c0 6.627 5.373 12 12 12h52v190.015c-58.936-7.399-123.82-39.679-144.117-94.015h35.146c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0L4.485 331.515C-3.074 339.074 2.28 352 12.971 352zM288 64c17.645 0 32 14.355 32 32s-14.355 32-32 32-32-14.355-32-32 14.355-32 32-32z"&gt;&lt;/path&gt;&lt;/svg&gt; Anchor-based Methods 


### **Between Patients Score Change Approach**

&gt; - The mean difference or mean change difference between groups with responder and non-responder of the anchor
&gt; - Let `\(\bar{\Delta}_{r}\)` and `\(\bar{\Delta}_{nr}\)` be the mean change in the responder and non-responder group


**MCID**: `\(\bar{\Delta}_{r} - \bar{\Delta}_{nr}\)` `\(\rightarrow\)` the group difference


.pull-left[&lt;img src="assets/imgs/mcid-anchor-grp-diff.png" width="95%"&gt;]
.pull-right[
Note that when obtaining the pooled variance of `\(\Delta_{r}\)` and `\(\Delta_{nr}\)` , `\(s_{pooled}\)`

`$$Effect~Size = \frac{\bar{\Delta}_{r} - \bar{\Delta}_{nr}}{s_{pooled}}$$`

`\(s_{pooled} = \sqrt{\frac{(n_{1} -1)s^{2}_{\Delta_{r}} + (n_{2}-1)s^{2}_{\Delta_{nr}}}{n_{1} + n_{2} - 2}}\)`


`\(\rightarrow\)` can be used to **sample size calculation**

]

---

# &lt;svg viewBox="0 0 576 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M12.971 352h32.394C67.172 454.735 181.944 512 288 512c106.229 0 220.853-57.38 242.635-160h32.394c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0l-67.029 67.029c-7.56 7.56-2.206 20.485 8.485 20.485h35.146c-20.29 54.317-84.963 86.588-144.117 94.015V256h52c6.627 0 12-5.373 12-12v-40c0-6.627-5.373-12-12-12h-52v-5.47c37.281-13.178 63.995-48.725 64-90.518C384.005 43.772 341.605.738 289.37.01 235.723-.739 192 42.525 192 96c0 41.798 26.716 77.35 64 90.53V192h-52c-6.627 0-12 5.373-12 12v40c0 6.627 5.373 12 12 12h52v190.015c-58.936-7.399-123.82-39.679-144.117-94.015h35.146c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0L4.485 331.515C-3.074 339.074 2.28 352 12.971 352zM288 64c17.645 0 32 14.355 32 32s-14.355 32-32 32-32-14.355-32-32 14.355-32 32-32z"&gt;&lt;/path&gt;&lt;/svg&gt; Anchor-based Methods 


### **ROC curves Approach**

&gt; - `\(Y\in\{0, 1\}\)` : anchor scores splitted into two categories
&gt;    - `\(Y = 1\)` : clinically meaningful; `\(Y = 0\)` : otherwise
&gt; - `\(X = [X_{1}, X_{0}]^T\)` : diagnostic measurement that fall into `\(Y_{1}\)` and `\(Y_{0}\)`, respectively `\((X \in \mathcal{R}^1)\)` 
&gt; - The `\(2\times 2\)` table of a dichotomous test

&lt;table class=" lightable-classic" style='font-family: "Arial Narrow", "Source Sans Pro", sans-serif; width: auto !important; margin-left: auto; margin-right: auto;border-bottom: 0;'&gt;
 &lt;thead&gt;
&lt;tr&gt;
&lt;th style="empty-cells: hide;" colspan="1"&gt;&lt;/th&gt;
&lt;th style="padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2"&gt;&lt;div style="border-bottom: 1px solid #111111; margin-bottom: -1px; "&gt;Anchor&lt;/div&gt;&lt;/th&gt;
&lt;th style="empty-cells: hide;" colspan="1"&gt;&lt;/th&gt;
&lt;/tr&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Diagnositc measurement &lt;/th&gt;
   &lt;th style="text-align:center;"&gt; \(Y_{1}\) &lt;/th&gt;
   &lt;th style="text-align:center;"&gt; \(Y_{0}\) &lt;/th&gt;
   &lt;th style="text-align:center;"&gt; Total &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; \(X_{1}\) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; TP &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; FP &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; \(m_{1}\) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; \(X_{0}\) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; FN &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; TN &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; \(m_{0}\) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Total &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; \(n_{1}\) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; \(n_{0}\) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; N &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;tfoot&gt;
&lt;tr&gt;&lt;td style="padding: 0; " colspan="100%"&gt;&lt;span style="font-style: italic;"&gt;Note: &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="padding: 0; " colspan="100%"&gt;
&lt;sup&gt;&lt;/sup&gt; TP: true positive; TN: true negative; FP: false positive; FN: false negative&lt;/td&gt;&lt;/tr&gt;
&lt;/tfoot&gt;
&lt;/table&gt;

---

# &lt;svg viewBox="0 0 576 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M12.971 352h32.394C67.172 454.735 181.944 512 288 512c106.229 0 220.853-57.38 242.635-160h32.394c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0l-67.029 67.029c-7.56 7.56-2.206 20.485 8.485 20.485h35.146c-20.29 54.317-84.963 86.588-144.117 94.015V256h52c6.627 0 12-5.373 12-12v-40c0-6.627-5.373-12-12-12h-52v-5.47c37.281-13.178 63.995-48.725 64-90.518C384.005 43.772 341.605.738 289.37.01 235.723-.739 192 42.525 192 96c0 41.798 26.716 77.35 64 90.53V192h-52c-6.627 0-12 5.373-12 12v40c0 6.627 5.373 12 12 12h52v190.015c-58.936-7.399-123.82-39.679-144.117-94.015h35.146c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0L4.485 331.515C-3.074 339.074 2.28 352 12.971 352zM288 64c17.645 0 32 14.355 32 32s-14.355 32-32 32-32-14.355-32-32 14.355-32 32-32z"&gt;&lt;/path&gt;&lt;/svg&gt; Anchor-based Methods 


### **ROC curves Approach**

&gt; - ROC: Receiver Operating Charcteristic 
&gt; - `\(\mathrm{Sensitivity} = P(X_{1}|Y_{1}) = \frac{TP}{TP + FN} = \frac{TP}{n_{1}}\)` `\(\rightarrow\)` True positive rate (TPR)
&gt; - `\(\mathrm{Specificity} = P(X_{0}|Y_{0}) = \frac{TN}{TN + FP} = \frac{TN}{n_{0}}\)` `\(\rightarrow\)` True negative rate (TNR)
&gt; - False positive rate (FPR) = 1 - Specificity
&gt; - Considering all possible thresholds `\(c\)`, ROC curve can be defined as a function of `\(c\)`

`$$\mathrm{ROC}(\cdot) = \{\mathrm{FPR}(c), \mathrm{TPR}(c), c \in (-\infty, +\infty) \}$$`
where


`$$\begin{aligned}\mathrm{TPR}(c) &amp;= P(X &gt; c|Y_{1}) \\ \mathrm{FPR}(c) &amp;=P(X&gt;c|Y_0)\end{aligned}$$`


#### **MCID**: `\(\max_{c}\left\{ P(Y = 1, X\geq c)/P(X\geq c) + P(Y = 0, X\leq c)/P(X\leq c)  \right\}\)`

&gt; - maximizing the sum of sensitivity and specificiy `\(\rightarrow\)` **Youden index**
&gt; - Calculate the area under the ROC curve (AUROC) `\(\rightarrow\)` general performance (classification) of `\(X\)`

---

# &lt;svg viewBox="0 0 576 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M12.971 352h32.394C67.172 454.735 181.944 512 288 512c106.229 0 220.853-57.38 242.635-160h32.394c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0l-67.029 67.029c-7.56 7.56-2.206 20.485 8.485 20.485h35.146c-20.29 54.317-84.963 86.588-144.117 94.015V256h52c6.627 0 12-5.373 12-12v-40c0-6.627-5.373-12-12-12h-52v-5.47c37.281-13.178 63.995-48.725 64-90.518C384.005 43.772 341.605.738 289.37.01 235.723-.739 192 42.525 192 96c0 41.798 26.716 77.35 64 90.53V192h-52c-6.627 0-12 5.373-12 12v40c0 6.627 5.373 12 12 12h52v190.015c-58.936-7.399-123.82-39.679-144.117-94.015h35.146c10.691 0 16.045-12.926 8.485-20.485l-67.029-67.029c-4.686-4.686-12.284-4.686-16.971 0L4.485 331.515C-3.074 339.074 2.28 352 12.971 352zM288 64c17.645 0 32 14.355 32 32s-14.355 32-32 32-32-14.355-32-32 14.355-32 32-32z"&gt;&lt;/path&gt;&lt;/svg&gt; Anchor-based Methods 


### **ROC curves Approach**


&lt;img src="Figures/roc-example-1.gif" width="80%" style="display: block; margin: auto;" /&gt;

.center[##### Epitomized from https://www.r-bloggers.com/2019/01/roc-curves/]


&gt; - Considering multiple covariates, **binary logistic regression** is useful



---

# &lt;img src="assets/icons/probability-dist.svg" width="7%"/&gt; Distribution-based Methods 

### Based on statistical distribution

&gt; - Commonly use the change of scores and its variability
&gt; - Explain the change beyond some level of random variation
&gt; - Easily appliable when absence of the anchor to interpret the change of PRO scores
&gt; - Distictly different from the MCID
&gt; - Sample-specific


### In Regulatory 

&gt; - Pharmaceutical Benefits Advisory Committee (PBAC): favor of the anchor-based approach
&gt; - Food and Drug Administration: distribution-based approach roles to support the anchor-based approach

---
# &lt;img src="assets/icons/probability-dist.svg" width="7%"/&gt; Distribution-based Methods 

### ** `\(0.5 \times \mathrm{SD}\)` **

&gt; - When the distribution are approximately normal, `\(0.5\times SD\)` is closed to the effect size of 0.5
&gt; - **MCID**: `\(0.5\times SD\)` of changes in the instrument

### **Standard Error of Measurement (SEM)**

&gt; - The variation in the score due to the un reliability of the scale or measure used
&gt; - Sample indepdendent
&gt; - Express the original metric of the instrument
&gt; - SEM is defined with the given reliability of the instrument, `\(r_{xx}\)`

`$$\mathrm{SEM} = SD_{\mathrm{baseline}} \sqrt{1 - r_{xx}}$$`


`\(r_{xx}\)` can be Cronbach's `\(\alpha\)` or intraclass correlation coefficient (ICC)

#### **MCID**: `\(1\times \mathrm{SEM}\)` `\(\rightarrow\)` closely related to PROs measured by the anchor-based approach


???

SEMì€ ì˜¤ì°¨ì˜ ë³€ë™ì„±(ì¦‰, ì¸¡ì • ì˜¤ì°¨ì˜ í‘œì¤€í¸ì°¨)ì„ ë³´ì—¬ì£¼ëŠ” ê°œë…ìœ¼ë¡œ 
ë„êµ¬ì˜ í‘œì¤€í¸ì°¨ Ã— `\(\sqrt{1 - ë„êµ¬ì˜ ì‹ ë¢°ê³„ìˆ˜}\)`ë¡œ ê³„ì‚°í• 
ìˆ˜ ìˆëŠ”ë°, ì¤‘ìš”í•œ ë³€í™”ë¥¼ ì¶”ì •í•  ë•Œ ìì£¼ ì‚¬ìš©ëœë‹¤. SEMì€ ì¤€ê±°ê¸°ë°˜ë²•ìœ¼ë¡œ 
ì¸¡ì •í•œ ë‹¤ì–‘í•œ PRO ë„êµ¬ì˜ MCIDì™€ ë§¤ìš° ë°€ì ‘í•œ ì—°ê´€ì„±ì„ ë³´ì´ëŠ” ê²½í–¥ì´ ìˆì–´,
SEMì„ ì´ìš©í•˜ì—¬ MCID ì¶”ì • ì‹œ ì¤‘ìš”í•œ ê¸°ì¤€ê°’ìœ¼ë¡œ ìì£¼ ì‚¬ìš©ë˜ê³  ìˆë‹¤


---

# &lt;img src="assets/icons/probability-dist.svg" width="7%"/&gt; Distribution-based Methods 

### **Reliable Change Index (RCI)**

&gt; - Evaluate whether a change over time of an individual score is considered statistically significant. 
&gt; - Let the change from baseline be `\(\delta\)`, 

`$$\mathrm{RCI} = \frac{\delta}{SE_{\delta}} = \frac{\delta}{\sqrt{1.96\times SEM}}$$` 
 &gt; Closely related to the MDC. 
 &gt; `\(\mathrm{RCI} &gt; 1.96\)` considered to be statistically significant 
 
 
 **MCID**: `\(1.96 \times SD_{b}\sqrt{2(1 - r_{xx})}\)`, `\(SD_{b}\)` : SD of the baseline 


### **Effect Size**

`$$ES = \frac{x_{2} - x_{1}}{SD_{b}}$$`

&gt; Following Cohen's Criteria 


**MCID**: `\(c\times SD_{b}\)` . `\(c\)` can be 0.2, 0.5, 0.8. 




---

class: inverse, center, middle

# &lt;img src="assets/icons/discussion.svg" width="7%"/&gt; Discussion

---

# &lt;svg viewBox="0 0 640 512" style="height:1em;fill:currentColor;position:relative;display:inline-block;top:.1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M104 96H56c-13.3 0-24 10.7-24 24v104H8c-4.4 0-8 3.6-8 8v48c0 4.4 3.6 8 8 8h24v104c0 13.3 10.7 24 24 24h48c13.3 0 24-10.7 24-24V120c0-13.3-10.7-24-24-24zm528 128h-24V120c0-13.3-10.7-24-24-24h-48c-13.3 0-24 10.7-24 24v272c0 13.3 10.7 24 24 24h48c13.3 0 24-10.7 24-24V288h24c4.4 0 8-3.6 8-8v-48c0-4.4-3.6-8-8-8zM456 32h-48c-13.3 0-24 10.7-24 24v168H256V56c0-13.3-10.7-24-24-24h-48c-13.3 0-24 10.7-24 24v400c0 13.3 10.7 24 24 24h48c13.3 0 24-10.7 24-24V288h128v168c0 13.3 10.7 24 24 24h48c13.3 0 24-10.7 24-24V56c0-13.3-10.7-24-24-24z"&gt;&lt;/path&gt;&lt;/svg&gt; Strengths of MCID

&lt;br&gt;

### 1. Threshold to detect the change beyond random errors 

### 2. Patient's based perspective `\(\rightarrow\)` guiding clinical decision making

### 3. The evidence to determine sample size calculations 


---

# &lt;img src="assets/icons/weak.svg" width="7%"/&gt; Weakness of MCID


### 1. NOT a universal fixed attribute 

&gt; - difficult to transfer across populations, disease-specifit states


### 2. TOO MANY methodologies to estimate MCIDs. 

&gt; - Dependant on the methodology chosen


### 3. Absence of a single, universally accepted MCID value


### 4. Not taking account into the cost of the treatment




---
class: inverse, center, middle

# Thank you for patients!!



--
&lt;br&gt;&lt;br&gt;
# Question??




---

# References

[1] A. G. Copay, B. R. Subach, S. D. Glassman, et al. "Understanding
the minimum clinically important difference: a review of concepts and
methods". In: _The Spine Journal_ 7.5 (2007), pp. 541-546.

[2] F. Y. Edgeworth. "Methods of statistics". In: _Journal of the
Statistical Society of London_ (1885), pp. 181-217.

[3] R. Jaeschke, J. Singer, and G. H. Guyatt. "Measurement of health
status: ascertaining the minimal clinically important difference". In:
_Controlled clinical trials_ 10.4 (1989), pp. 407-415.

[4] H. J. SchÃ¼nemann, M. Puhan, R. Goldstein, et al. "Measurement
properties and interpretability of the Chronic respiratory disease
questionnaire (CRQ)". In: _COPD: journal of chronic obstructive
pulmonary disease_ 2.1 (2005), pp. 81-89.

[5] R. L. Wasserstein, N. A. Lazar, and others. "The ASAâ€™s statement
on p-values: context, process, and purpose". In: _The American
Statistician_ 70.2 (2016), pp. 129-133.






    </textarea>
<style data-target="print-only">@media screen {.remark-slide-container{display:block;}.remark-slide-scaler{box-shadow:none;}}</style>
<script src="https://remarkjs.com/downloads/remark-latest.min.js"></script>
<script>var slideshow = remark.create({
"highlightStyle": "github",
"highlightLines": true,
"countIncrementalSlides": false
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function(d) {
  var s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})(document);

(function(d) {
  var el = d.getElementsByClassName("remark-slides-area");
  if (!el) return;
  var slide, slides = slideshow.getSlides(), els = el[0].children;
  for (var i = 1; i < slides.length; i++) {
    slide = slides[i];
    if (slide.properties.continued === "true" || slide.properties.count === "false") {
      els[i - 1].className += ' has-continuation';
    }
  }
  var s = d.createElement("style");
  s.type = "text/css"; s.innerHTML = "@media print { .has-continuation { display: none; } }";
  d.head.appendChild(s);
})(document);
// delete the temporary CSS (for displaying all slides initially) when the user
// starts to view slides
(function() {
  var deleted = false;
  slideshow.on('beforeShowSlide', function(slide) {
    if (deleted) return;
    var sheets = document.styleSheets, node;
    for (var i = 0; i < sheets.length; i++) {
      node = sheets[i].ownerNode;
      if (node.dataset["target"] !== "print-only") continue;
      node.parentNode.removeChild(node);
    }
    deleted = true;
  });
})();
(function() {
  "use strict"
  // Replace <script> tags in slides area to make them executable
  var scripts = document.querySelectorAll(
    '.remark-slides-area .remark-slide-container script'
  );
  if (!scripts.length) return;
  for (var i = 0; i < scripts.length; i++) {
    var s = document.createElement('script');
    var code = document.createTextNode(scripts[i].textContent);
    s.appendChild(code);
    var scriptAttrs = scripts[i].attributes;
    for (var j = 0; j < scriptAttrs.length; j++) {
      s.setAttribute(scriptAttrs[j].name, scriptAttrs[j].value);
    }
    scripts[i].parentElement.replaceChild(s, scripts[i]);
  }
})();
(function() {
  var links = document.getElementsByTagName('a');
  for (var i = 0; i < links.length; i++) {
    if (/^(https?:)?\/\//.test(links[i].getAttribute('href'))) {
      links[i].target = '_blank';
    }
  }
})();
// adds .remark-code-has-line-highlighted class to <pre> parent elements
// of code chunks containing highlighted lines with class .remark-code-line-highlighted
(function(d) {
  const hlines = d.querySelectorAll('.remark-code-line-highlighted');
  const preParents = [];
  const findPreParent = function(line, p = 0) {
    if (p > 1) return null; // traverse up no further than grandparent
    const el = line.parentElement;
    return el.tagName === "PRE" ? el : findPreParent(el, ++p);
  };

  for (let line of hlines) {
    let pre = findPreParent(line);
    if (pre && !preParents.includes(pre)) preParents.push(pre);
  }
  preParents.forEach(p => p.classList.add("remark-code-has-line-highlighted"));
})(document);</script>

<script>
slideshow._releaseMath = function(el) {
  var i, text, code, codes = el.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
};
slideshow._releaseMath(document);
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
